Healthcare Live Meetings 1

• GLG Education: Skills Seminar -- Drafting Effective Surveys
• GLG Seminar (San Francisco): Diabetes and Obesity Industries Seminar
• GLG Seminar and Tour: Genotyping and Gene Sequencing
• GLG Seminar: (BOS) Anti-Platelet Therapy with Gregory Giugliano, MD
• GLG Seminar: (BOS) Biostatistics
• GLG Seminar: (BOS) Cardiology with Alexander Graham Turpie, MD
• GLG Seminar: (BOS) Clinical Laboratory Trends
• GLG Seminar: (BOS) Fundamental Issues in Clinical Trials
• GLG Seminar: (BOS) Healthcare Trends in China
• GLG Seminar: (BOS) Hematology with Arnold Freedman, MD
• GLG Seminar: (BOS) Hot Topics from ADA 2009 with Kelly Close
• GLG Seminar: (BOS) Interventional Cardiology with Frederic Resnic, MD
• GLG Seminar: (BOS) Key Design Issues in Clinical Trials with Thomas Fleming, PhD
• GLG Seminar: (BOS) Next Generation Sequencing with Richard Wilson, PhD
• GLG Seminar: (BOS) Non-Inferiority Trials with Thomas Fleming, PhD
• GLG Seminar: (BOS) Preview of ADA 2009 with Ralph DeFronzo, MD
• GLG Seminar: (BOS) Screening and Confirmatory Trials with Thomas Fleming, PhD
• GLG Seminar: (BOS) Surrogate Endpoints in Biostatistics with Thomas Fleming, PhD
• GLG Seminar: (BOS) Vaccines
• GLG Seminar: (Hong Kong) Active Pharmaceutical Ingredient (API) Manufacturing Industry in China
• GLG Seminar: (Hong Kong) Consolidation Trends - China Pharma Winners and Losers
• GLG Seminar: (Hong Kong) Medical Devices in China
• GLG Seminar: (Hong Kong) New Chinese Healthcare Reform
• GLG Seminar: (London) Pharmaceutical Pricing and Reimbursement
• GLG Seminar: (NYC) Antiarrhythmics with Michael Kim, MD
• GLG Seminar: (NYC) Clinical Laboratory Trends
• GLG Seminar: (NYC) Fundamental Issues in Clinical Trials
• GLG Seminar: (NYC) Genitourinary Cancers with David Solit, MD
• GLG Seminar: (NYC) Growth Opportunities for Healthcare Technology Companies
• GLG Seminar: (NYC) Healthcare Trends in China
• GLG Seminar: (NYC) Healthcare Trends in China
• GLG Seminar: (NYC) Hematology with Frank Giles, MD
• GLG Seminar: (NYC) Hot Topics from ADA 2009 with Kelly Close
• GLG Seminar: (NYC) Interventional Cardiology with Frederic Resnic, MD
• GLG Seminar: (NYC) Key Design Issues in Clinical Trials with Thomas Fleming, PhD
• GLG Seminar: (NYC) Non-Inferiority Trials with Thomas Fleming, PhD
• GLG Seminar: (NYC) Pharma/Biotech R&D Spending
• GLG Seminar: (NYC) Preview of ADA 2009 with Ralph DeFronzo, MD
• GLG Seminar: (NYC) Screening and Confirmatory Trials with Thomas Fleming, PhD
• GLG Seminar: (NYC) Statistical Issues in Clinical Trials
• GLG Seminar: (NYC) Surrogate Endpoints in Biostatistics with Thomas Fleming, PhD
• GLG Seminar: (NYC) Vaccines
• GLG Seminar: (Palo Alto) Glaucoma Therapies and Devices
• GLG Seminar: (Palo Alto) Heart Failure
• GLG Seminar: (Palo Alto) Minimally Invasive Procedures in Gynecology with Donald Galen, MD
• GLG Seminar: (Palo Alto) Parkinson's Disease with J. William Langston, MD
• GLG Seminar: (Palo Alto) Preview of 2009 ADA with Kelly Close
• GLG Seminar: (Palo Alto) Sleep Disorders
• GLG Seminar: (Palo Alto) Urology with Robert Pugach, MD
• GLG Seminar: (SF) Biostatistics
• GLG Seminar: (SF) Clinical Laboratory Trends
• GLG Seminar: (SF) Cosmetic Dermatology with Christine Lee, MD
• GLG Seminar: (SF) Diabetes with Xavier Pi-Sunyer, MD
• GLG Seminar: (SF) Fundamental Issues in Clinical Trials
• GLG Seminar: (SF) Infectious Diseases with Richard Haubrich, MD
• GLG Seminar: (SF) Interventional Cardiology with Alan Yeung, MD
• GLG Seminar: (SF) Key Design Issues in Clinical Trials with Thomas Fleming, PhD
• GLG Seminar: (SF) Non-Inferiority Trials with Thomas Fleming, PhD
• GLG Seminar: (SF) Screening and Confirmatory Trials with Thomas Fleming, PhD
• GLG Seminar: (SF) Vaccines
• GLG Seminar: (Tokyo) Chinese Healthcare & Growth Opps for Japanese Pharma and Device Companies
• GLG Seminar: (Tokyo) India Healthcare & Growth Opps for Japanese Pharma & Device Companies
• GLG Seminar: (Tokyo) State of Healthcare Industry in Japan & Globalization Moves of Japanese Players
• GLG Seminar: Breast and Lung Cancer Panel
• GLG Seminar: Colorectal Cancer
• GLG Seminar: Diabetes and Obesity
• GLG Seminar: Diabetes and Obesity Panel
• GLG Seminar: Digital Mammography
• GLG Seminar: Dynamic Stabilization Surgery Viewing
• GLG Seminar: Lung and Colorectal Cancer Panel
• GLG Seminar: Molecular Platforms and Laboratory Technology
• GLG Seminar: Private Hospital Market in China
• GLG Seminar: Rheumatology
• GLG Seminar:(SF) Lipid Management Seminar
• GLG Symposium: (London) Opportunities and Challenges in 2009
• GLG Webcast: Consolidation Trends - China Pharma on May 22, 2009 at 7:30AM ET
• GLG Webcast: Domestic Healthcare Policy – May 15, 2009 at 2:00 PM ET/11:00 AM PT
• GLG Webcast: Growth Opportunities for Healthcare Technology Companies
• GLG Webcast: Pharmacy Trends with Jan Berger, MD – June 12, 2009 at 2:00 PM ET
• GLGi: Biostatistics- Addressing Safety of Drugs/Biologics, and Selected Topics Seminar
• GLGi: 2008 Formulary Design and Pricing
• GLGi: Advances in Basic Skin Science
• GLGi: After Katrina: Hospital Closures
• GLGi: After Katrina: Reporting Katrina Effects in Earnings: GAAP & Practice
• GLGi: Alzheimer’s Disease
• GLGi: Alzheimer's Disease
• GLGi: Alzheimer's Disease
• GLGi: Alzheimer's Disease
• GLGi: Antibacterials
• GLGi: Attention Deficit Hyperactivity Disorder - ADHD
• GLGi: Attention Deficit Hyperactivity Disorder (ADHD)
• GLGi: Biostatistics - Addressing Safety of Drugs/Biologics, and Other Selected Topics
• GLGi: Biostatistics - Addressing the Safety of Drugs/Biologics and Other Selected Topics
• GLGi: Biostatistics Part II
• GLGi: Biostatistics Part III
• GLGi: Biostatistics Part III
• GLGi: Biostatistics Part III
• GLGi: Biostatistics: Current Controversial Issues in Clinical Trials Design and Conduct
• GLGi: Biostatistics: Current Controversial Issues in Clinical Trials Design and Conduct
• GLGi: Biostatistics: Current Controversial Issues in Clinical Trials Design and Conduct
• GLGi: Biostatistics: Current Issues in Monitoring Clinical Trials
• GLGi: Biostatistics: Issues in Screening and Confirmatory Trials
• GLGi: Biostatistics: Issues in Screening and Confirmatory Trials
• GLGi: Biostatistics: Issues in Screening and Confirmatory Trials
• GLGi: Biostatistics: Issues of Regulatory Interest
• GLGi: Biostatistics: Issues of Regulatory Interest
• GLGi: Biostatistics: Issues of Regulatory Interest
• GLGi: Biostatistics: Sample Size and Regulatory Issues
• GLGi: Biostatistics: Sample Size and Regulatory Issues
• GLGi: Biostatistics: Sample Size and Regulatory Issues
• GLGi: Breast Cancer
• GLGi: Cardiology Grand Rounds
• GLGi: Cardiology Grand Rounds
• GLGi: Cardiology Grand Rounds
• GLGi: Cardiology Grand Rounds
• GLGi: Cardiology Grand Rounds
• GLGi: Cardiology Grand Rounds
• GLGi: Cardiology Grand Rounds
• GLGi: Cardiology Grand Rounds
• GLGi: Cardiology Grand Rounds
• GLGi: Cardiology Grand Rounds
• GLGi: Chronic Kidney Disease Treatment Guidelines
• GLGi: Chronic Kidney Disease Treatment Guidelines
• GLGi: Cosmetic Dermatology
• GLGi: Current Issues in Monitoring Clinical Trials
• GLGi: Current Issues in Monitoring Clinical Trials
• GLGi: Current Issues in Non-Inferiority Trials
• GLGi: Current Issues in Non-Inferiority Trials
• GLGi: Current Issues in Non-Inferiority Trials
• GLGi: Cystic Fibrosis
• GLGi: Dental Implants
• GLGi: Dental Implants
• GLGi: Diabetes
• GLGi: Diabetes
• GLGi: Diabetes and Obesity Grand Rounds
• GLGi: Diabetes and Obesity
• GLGi: Diabetes and Obesity Grand Rounds
• GLGi: Diabetes and Obesity Grand Rounds
• GLGi: Diabetes and Obesity Grand Rounds
• GLGi: Disease Management
• GLGi: Drug Delivery Technologies
• GLGi: Drug Treatment of Atherosclerosis
• GLGi: Early Developments in Cancer Therapeutics
• GLGi: Electrophysiology
• GLGi: Emerging Bacterial Infections
• GLGi: Emerging Therapies for Hepatitis C
• GLGi: Emerging Therapies for Hepatitis C
• GLGi: Emerging Therapies for HIV
• GLGi: Emerging Therapies for HIV
• GLGi: Emerging Therapies for HIV
• GLGi: Emerging Therapies for HIV Grand Rounds
• GLGi: Emerging Therapies for Prostate Cancer
• GLGi: European Regulatory Process for Drugs
• GLGi: Genomic and Proteomic Technologies Seminar
• GLGi: Genotyping Technologies
• GLGi: GLG Hosts Nielsen BuzzMetrics – Analyzing Consumer Sentiment Regarding Injectable Aesthetics
• GLGi: Gulf Coast Reconstruction and the Home Building Industry
• GLGi: Healthcare Finance
• GLGi: Healthcare Finance
• GLGi: Heart Failure Grand Rounds
• GLGi: Hematologic Malignancies Grand Rounds
• GLGi: Hematologic Malignancy Grand Rounds
• GLGi: Hematologic Malignancy Grand Rounds
• GLGi: Hematologic Malignancy Grand Rounds
• GLGi: Hematology Grand Rounds
• GLGi: Hematology Grand Rounds
• GLGi: Hematology Grand Rounds
• GLGi: Hepatitis B and C
• GLGi: HIV
• GLGi: HIV & Infectious Diseases Grand Rounds
• GLGi: HIV & Infectious Diseases Grand Rounds
• GLGi: HIV Grand Rounds
• GLGi: HIV Grand Rounds
• GLGi: HIV Therapeutics
• GLGi: HIV Therapies
• GLGi: Human Immunodeficiency Virus (HIV)
• GLGi: Human Immunodeficiency Virus (HIV)
• GLGi: Hyperlipidemia Therapies and Drug Eluting Stents
• GLGi: Infectious Diseases Grand Rounds
• GLGi: Infectious Diseases Grand Rounds
• GLGi: Inflammatory Bowel Disease
• GLGi: Interventional Cardiology
• GLGi: Interventional Cardiology
• GLGi: Intraocular Lenses (IOLs)
• GLGi: Ion Channels in Oncology Drug Development
• GLGi: Ion Channels in Oncology Drug Development
• GLGi: Kyphoplasty Surgery Viewing
• GLGi: Lipid Management
• GLGi: Lipid Management
• GLGi: Lipid Management
• GLGi: Lipid Management
• GLGi: Lipid Management
• GLGi: Liver Disease
• GLGi: Liver Diseases Grand Rounds
• GLGi: Liver Diseases Grand Rounds
• GLGi: Long Term Acute Care Hospitals
• GLGi: Lung Cancer
• GLGi: Managed Care Formulary
• GLGi: Managed Care Formulary
• GLGi: Marine and Energy Insurance – Pricing and Coverage Pre and Post Katrina
• GLGi: Medicare and Medicaid
• GLGi: Medicare and Medicaid Programs
• GLGi: Microarray Facility Tour
• GLGi: Microarrays and DNA Sequencing
• GLGi: Multiple Sclerosis
• GLGi: Multiple Sclerosis
• GLGi: Multiple Sclerosis
• GLGi: Multiple Sclerosis
• GLGi: Navigating Changes to Medicare Part B
• GLGi: Navigating Changes to Medicare Part B
• GLGi: Nephrology 101
• GLGi: Nephrology 101
• GLGi: Nephrology 101
• GLGi: Nephrology 101
• GLGi: New Drug Application Process
• GLGi: Obesity
• GLGi: Obesity and Bariatric Surgery
• GLGi: Oncology
• GLGi: Oncology Grand Rounds
• GLGi: Oncology Grand Rounds
• GLGi: Ophthalmology
• GLGi: Ophthalmology Grand Rounds
• GLGi: Ophthalmology Grand Rounds
• GLGi: Orthopedics
• GLGi: Orthopedics
• GLGi: Osteoporosis
• GLGi: Osteoporosis
• GLGi: Pain Management - What's on the Horizon
• GLGi: Panel Review of the American Society of Hematology (ASH) 49th Annual Meeting
• GLGi: Pharmacy Benefit Management
• GLGi: Post-ASCO Review
• GLGi: Psoriasis and Medical Dermatology
• GLGi: Radiation Oncology
• GLGi: Rheumatoid Arthritis
• GLGi: Rheumatology Grand Rounds
• GLGi: Rheumatology Grand Rounds
• GLGi: Rheumatology Grand Rounds
• GLGi: Robotic Surgery in Urology
• GLGi: Sexual Dysfunction
• GLGi: Sleep Disorders: The Global Market for Devices and Pharmacologic Treatments
• GLGi: Sleep Disorders: The Global Market for Devices and Pharmacologic Treatments
• GLGi: Solid Tumors
• GLGi: Spinal Surgery Viewing
• GLGi: Spine Disease Treatments
• GLGi: Spine Fusions
• GLGi: Spine Surgery
• GLGi: Systemic Lupus Erythematosus
• GLGi: Targeted Therapies for Lung Cancer
• GLGi: Targeted Therapies for Ovarian Cancer
• GLGi: The Future of Managed Care
• GLGi: The Future of Managed Care
• GLGi: The Generic Drug Industry
• GLGi: The Generic Drug Industry
• GLGi: Urology
• GLGi: Urology
• GLGi: Wound Care Market
• Seminar: Clinical Chemistry Trends with Alan Wu, PhD (San Francisco)
• Seminar: Current Issues in Monitoring Clinical Trials with Thomas Fleming, PhD (Boston)
• Seminar: Current Issues in Monitoring Clinical Trials with Thomas Fleming, PhD (New York)
• Seminar: Current Issues in Monitoring Clinical Trials with Thomas Fleming, PhD (San Francisco)
• Seminar: Data Monitoring Committees with Thomas Fleming, PhD (Boston)
• Seminar: Data Monitoring Committees with Thomas Fleming, PhD (New York)
• Seminar: Data Monitoring Committees with Thomas Fleming, PhD (San Francisco)
• Seminar: Hot Topics at the Upcoming 51st Annual American Society of Hematology Meeting (Boston)
• Seminar: Hot Topics from Upcoming American Society of Hematology Meeting (New York)
• Seminar: Hot Topics from Upcoming American Society of Hematology Meeting (San Francisco)
• Seminar: Interventional Cardiology - Post-TCT 2009 Data Driven Analysis of Stent Market (New York)
• Seminar: Issues in Using PFS when Evaluating Oncology Products with Thomas Fleming, PhD
• Seminar: Issues in Using PFS when Evaluating Oncology Products with Thomas Fleming, PhD (Boston)
• Seminar: Issues in Using PFS when Evaluating Oncology Products with Thomas Fleming, PhD (New York)
• Teleconference: Cholesterol War – Merck’s Zetia vs. Abbott’s Niaspan (10:15 AM EST / 15:15 GMT)
• Teleconference: Future of Gaucher Disease Therapies (11:00 AM EST / 15:00 GMT)
• Teleconference: Who Will Win the Anti-Obesity Pill Race? (9:00 AM EST / 13:00 GMT)
• Teleconference: Will Benlysta be the Miracle Drug for Lupus? (10:00 AM EST / 15:00 GMT)
• Webcast: Discerning Hype from Substance in Clinical Trials (11:00 AM EDT / 16:00 BST)
• Webcast: How Will Oral Cladribine and FTY-720 Impact the Multiple Sclerosis Market?
• Webcast: Personalized Medicine Panel (2:00 PM EDT / 11:00 AM PDT / 19:00 BST)